Literature DB >> 8149855

Anti-neutrophil cytoplasmic antibodies (ANCA) and inflammatory bowel diseases in Chinese.

J Y Sung1, F K Chan, J Lawton, J C Leung, C T Liew, N W Leung, R Hsu, K N Lai.   

Abstract

Inflammatory bowel diseases are uncommon in the Chinese, but the incidence is rising. Their differentiation from infective colitis is often not clear-cut and diagnosing inflammatory bowel diseases can be difficult in Asia. We have studied Chinese patients with ulcerative colitis (N = 19) and Crohn's disease (N = 12) for anti-neutrophil cytoplasmic antibodies (ANCA) by indirect immunofluorescence (IIF) and enzyme-linked immunosorbent assays (ELISA). Patients with enteric fever (N = 29) and irritable bowel syndrome (N = 24) were recruited as controls. Seventy-three percent of ulcerative colitis patients exhibited either p-ANCA (31%) or c-ANCA (42%) by IIF. Twenty-five percent of Crohn's disease patients were found to be p-ANCA positive. However, these ANCA were nonreactive to anti-alpha granule, antiproteinase 3, antimyeloperoxidase, or antilactoferrin. All positive patients had extensive colitis. Sera collected from patients suffering from enteric fever and irritable bowel syndrome were negative for ANCA by IIF and ELISA. We concluded that the detection of ANCA is helpful in diagnosing inflammatory bowel diseases. Further attempts to characterize these autoantibodies are needed.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8149855     DOI: 10.1007/bf02087438

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  14 in total

1.  A distinct subset of antineutrophil cytoplasmic antibodies is associated with inflammatory bowel disease.

Authors:  A Saxon; F Shanahan; C Landers; T Ganz; S Targan
Journal:  J Allergy Clin Immunol       Date:  1990-08       Impact factor: 10.793

2.  Neutrophil cytoplasmic antibodies: a link between primary sclerosing cholangitis and ulcerative colitis.

Authors:  R H Duerr; S R Targan; C J Landers; N F LaRusso; K L Lindsay; R H Wiesner; F Shanahan
Journal:  Gastroenterology       Date:  1991-05       Impact factor: 22.682

3.  Chronic inflammatory bowel diseases in Singapore.

Authors:  H S Ng
Journal:  Singapore Med J       Date:  1989-02       Impact factor: 1.858

4.  A study of the prevalence and clinical pattern of non-specific ulcerative colitis in northern India.

Authors:  B N Tandon; A K Mathur; L N Mohapatra; H D Tandon; K L Wig
Journal:  Gut       Date:  1965-10       Impact factor: 23.059

5.  Ulcerative colitis in the tropics.

Authors:  H K Chuttani; S P Nigam; S K Sama; P C Dhanda; P S Gupta
Journal:  Br Med J       Date:  1967-10-28

6.  Detection and quantitation of anti-neutrophil cytoplasm antibodies in Wegener's granulomatosis by ELISA using affinity-purified antigen.

Authors:  J Lüdemann; B Utecht; W L Gross
Journal:  J Immunol Methods       Date:  1988-11-10       Impact factor: 2.303

7.  Anti-neutrophil antibodies in inflammatory bowel disease: prevalence and diagnostic role.

Authors:  G Cambridge; D S Rampton; T R Stevens; D A McCarthy; M Kamm; B Leaker
Journal:  Gut       Date:  1992-05       Impact factor: 23.059

8.  Inflammatory diseases of the bowel: a Malaysian experience.

Authors:  T K Ti
Journal:  Aust N Z J Surg       Date:  1979-08

9.  Anti-neutrophil cytoplasmic autoantibodies with specificity for myeloperoxidase in patients with systemic vasculitis and idiopathic necrotizing and crescentic glomerulonephritis.

Authors:  R J Falk; J C Jennette
Journal:  N Engl J Med       Date:  1988-06-23       Impact factor: 91.245

10.  Subcellular localization of the b-cytochrome component of the human neutrophil microbicidal oxidase: translocation during activation.

Authors:  N Borregaard; J M Heiple; E R Simons; R A Clark
Journal:  J Cell Biol       Date:  1983-07       Impact factor: 10.539

View more
  4 in total

1.  pANCA antibodies in patients with anterior uveitis: identification of a marker antibody usually associated with ulcerative colitis.

Authors:  L K Gordon; M Eggena; G N Holland; J M Weisz; J Braun
Journal:  J Clin Immunol       Date:  1998-07       Impact factor: 8.317

2.  Antineutrophil cytoplasmic antibodies in sera from colectomised ulcerative colitis patients and its relation to the presence of pouchitis.

Authors:  M Esteve; J Mallolas; J Klaassen; A Abad-Lacruz; F González-Huix; E Cabré; F Fernández-Bañares; X Bertrán; E Condom; J Martí-Ragué; M A Gassull
Journal:  Gut       Date:  1996-06       Impact factor: 23.059

3.  Nuclear localization of the antigen detected by ulcerative colitis-associated perinuclear antineutrophil cytoplasmic antibodies.

Authors:  P Billing; S Tahir; B Calfin; G Gagne; L Cobb; S Targan; A Vidrich
Journal:  Am J Pathol       Date:  1995-10       Impact factor: 4.307

4.  Segregation of pANCA antigenic recognition by DNase treatment of neutrophils: ulcerative colitis, type 1 autoimmune hepatitis, and primary sclerosing cholangitis.

Authors:  A Vidrich; J Lee; E James; L Cobb; S Targan
Journal:  J Clin Immunol       Date:  1995-11       Impact factor: 8.317

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.